These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

661 related items for PubMed ID: 17630108

  • 1. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
    Ismiil N, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Ackerman I, Thomas G, Covens A, Khalifa MA.
    Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
    [Abstract] [Full Text] [Related]

  • 2. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
    Ismiil ND, Rasty G, Ghorab Z, Nofech-Mozes S, Bernardini M, Thomas G, Ackerman I, Covens A, Khalifa MA.
    Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
    [Abstract] [Full Text] [Related]

  • 3. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
    Nascimento AF, Hirsch MS, Cviko A, Quade BJ, Nucci MR.
    Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709
    [Abstract] [Full Text] [Related]

  • 4. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis.
    Mittal KR, Barwick KW.
    Gynecol Oncol; 1993 May; 49(2):197-201. PubMed ID: 8504988
    [Abstract] [Full Text] [Related]

  • 5. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
    Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, Mychalczak BR, McKee B, Hoskins WJ, Barakat RR.
    Cancer; 2002 Jul 15; 95(2):316-21. PubMed ID: 12124832
    [Abstract] [Full Text] [Related]

  • 6. The significance of tumor involved adenomyosis in otherwise low-stage endometrioid adenocarcinoma.
    Hanley KZ, Dustin SM, Stoler MH, Atkins KA.
    Int J Gynecol Pathol; 2010 Sep 15; 29(5):445-51. PubMed ID: 20736770
    [Abstract] [Full Text] [Related]

  • 7. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma.
    Ali A, Black D, Soslow RA.
    Int J Gynecol Pathol; 2007 Apr 15; 26(2):115-23. PubMed ID: 17413976
    [Abstract] [Full Text] [Related]

  • 8. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
    Ohishi Y, Kaku T, Kobayashi H, Aishima S, Umekita Y, Wake N, Tsuneyoshi M.
    Hum Pathol; 2008 Oct 15; 39(10):1446-53. PubMed ID: 18619643
    [Abstract] [Full Text] [Related]

  • 9. Endometrial endometrioid adenocarcinoma: a pathologic analysis of 827 consecutive cases.
    Nofech-Mozes S, Ghorab Z, Ismiil N, Ackerman I, Thomas G, Barbera L, Covens A, Khalifa MA.
    Am J Clin Pathol; 2008 Jan 15; 129(1):110-4. PubMed ID: 18089496
    [Abstract] [Full Text] [Related]

  • 10. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis.
    Srodon M, Klein WM, Kurman RJ.
    Am J Surg Pathol; 2003 Jun 15; 27(6):786-9. PubMed ID: 12766582
    [Abstract] [Full Text] [Related]

  • 11. Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion.
    Quick CM, May T, Horowitz NS, Nucci MR.
    Int J Gynecol Pathol; 2012 Jul 15; 31(4):337-43. PubMed ID: 22653347
    [Abstract] [Full Text] [Related]

  • 12. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma.
    Soeda S, Nakamura N, Ozeki T, Nishiyama H, Hojo H, Yamada H, Abe M, Sato A.
    Gynecol Oncol; 2008 Apr 15; 109(1):122-8. PubMed ID: 18289648
    [Abstract] [Full Text] [Related]

  • 13. Endometrial carcinoma in adenomyosis: assessment of myometrial invasion on T2-weighted spin-echo and gadolinium-enhanced T1-weighted images.
    Utsunomiya D, Notsute S, Hayashida Y, Lwakatare F, Katabuchi H, Okamura H, Awai K, Yamashita Y.
    AJR Am J Roentgenol; 2004 Feb 15; 182(2):399-404. PubMed ID: 14736670
    [Abstract] [Full Text] [Related]

  • 14. Predictors of final histology in patients with endometrial cancer.
    Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, Bodurka DC.
    Gynecol Oncol; 2004 Dec 15; 95(3):463-8. PubMed ID: 15581947
    [Abstract] [Full Text] [Related]

  • 15. Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma.
    Stokes GN, Shelton JB, Zahn CM, Kendall BS.
    Gynecol Oncol; 2002 Jan 15; 84(1):58-61. PubMed ID: 11748977
    [Abstract] [Full Text] [Related]

  • 16. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
    Lee KB, Ki KD, Lee JM, Lee JK, Kim JW, Cho CH, Kim SM, Park SY, Jeong DH, Kim KT.
    Ann Surg Oncol; 2009 Oct 15; 16(10):2882-7. PubMed ID: 19484311
    [Abstract] [Full Text] [Related]

  • 17. Intraoperative gross assessment of myometrial invasion and cervical involvement in endometrial cancer: Role of tumor grade and size.
    Fotiou S, Vlahos N, Kondi-Pafiti A, Zarganis P, Papakonstantinou K, Creatsas G.
    Gynecol Oncol; 2009 Mar 15; 112(3):517-20. PubMed ID: 19117598
    [Abstract] [Full Text] [Related]

  • 18. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage I-II endometrioid-type endometrial cancer.
    Gadducci A, Cavazzana A, Cosio S, DI Cristofano C, Tana R, Fanucchi A, Teti G, Cristofani R, Genazzani AR.
    Anticancer Res; 2009 May 15; 29(5):1715-20. PubMed ID: 19443392
    [Abstract] [Full Text] [Related]

  • 19. Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia.
    Janicek MF, Rosenshein NB.
    Gynecol Oncol; 1994 Mar 15; 52(3):373-8. PubMed ID: 8157194
    [Abstract] [Full Text] [Related]

  • 20. Reliability of magnetic resonance imaging in assessing myometrial invasion absence in endometrial carcinoma.
    Suh DS, Kim JK, Kim KR, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH.
    Acta Obstet Gynecol Scand; 2009 Mar 15; 88(9):990-3. PubMed ID: 19636979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.